×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Lexicon Pharmaceuticals Inc. (LXRX) NASDAQ

$2.39 0.20 (9.13%)

Market Cap: $539.26M

As of 03/28/24 03:59 PM EDT. Market closed.

(LXRX)

Lexicon Pharmaceuticals Inc. (LXRX)
NASDAQ

$2.39
0.20 (9.13%)

Market Cap: $539.26M

As of 03/28/24 03:59 PM EDT. Market closed.

Add to Portfolio

corporate overview lexicon pharmaceuticals is a biopharmaceutical company that has harnessed the power of genetics for drug discovery. our research team has generated a pipeline of novel drug candidates in clinical development across a broad range of indications. the genome: our source of discovery we have applied gene knockout technology to thousands of potential drug targets encoded in the ... read more

corporate overview lexicon pharmaceuticals is a biopharmaceutical company that has harnessed the power of genetics for drug discovery. our research team has generated a pipeline of novel drug candidates in clinical development across a broad range of indications. the genome: our source of discovery we have applied gene knockout technology to thousands of potential drug targets encoded in the human genome. our scientists have gained a thorough understanding of target biology and identified new points of intervention for future therapies. we have integrated a series of recombinant dna and chemistry technologies into a systematic drug discovery and development process. our unique knowledge of targets from the human genome has allowed us to better evaluate and advance novel drug candidates with great promise for patients. a diverse pipeline of targeted therapies our genomics-based approach to drug discovery has enabled our scientists to select drug targets across a broad range of indicatio read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO Compensation (Base)
$634,159
CEO Compensation (Total)
$3.12M
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
304
CEO Compensation (Base)
$634,159
CEO Compensation (Total)
$3.12M
Address
.
PRICE CHART FOR LEXICON PHARMACEUTICALS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.14
Previous Close
$2.19
Days Range
$2 - $2.28
52 week range
$0.92 - $3.79
Volume
7,058,993
Avg. Volume (30 days)
5,092,202
Market Cap
$539.26M
Dividend Yield
-
P/E
(3.04)
Shares Outstanding
246,236,753
Open
$2.14
Previous Close
$2.19
Days Range
$2 - $2.28
52 week range
$0.92 - $3.79
Volume
7,058,993
Avg. Volume (30 days)
5,092,202
Market Cap
$539.26M
Dividend Yield
-
P/E
(3.04)
Shares Outstanding
246,236,753
FINANCIAL STATEMENTS FOR LEXICON PHARMACEUTICALS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR LEXICON PHARMACEUTICALS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Artal International S.C.A.DirectorMar 13, 2024 Option Exercise$108.501,150,922124,875,0371,150,922Mar 13, 2024, 09:22 PM
Alexander KristenVP, Finance and AccountingFeb 28, 2024 Option Exercise$2.6211,79330,89847,800Feb 29, 2024, 04:33 PM
WADE JEFFREY LPresident and CFOFeb 28, 2024 Option Exercise$2.6237,69198,750324,214Feb 29, 2024, 04:32 PM
McDermott WendyVP, Human ResourcesFeb 28, 2024 Option Exercise$2.6222,42558,75352,694Feb 29, 2024, 04:31 PM
MAIN ALAN JEVP, Innov & Chem SciencesFeb 28, 2024 Option Exercise$2.6224,40863,949255,724Feb 29, 2024, 04:30 PM
Kassler-Taub Kenneth B.SVP, Regulatory & QAFeb 28, 2024 Option Exercise$2.6224,35363,805162,672Feb 29, 2024, 04:29 PM
Granowitz Craig BSVP, Chief Medical OfficerFeb 28, 2024 Option Exercise$2.6231,26581,91447,626Feb 29, 2024, 04:28 PM
Crum Brian TSVP, General Counsel & Secr.Feb 28, 2024 Option Exercise$2.6225,60467,082177,497Feb 29, 2024, 04:27 PM
COATS LONNELChief Executive OfficerFeb 28, 2024 Option Exercise$2.6261,371160,7921,098,068Feb 29, 2024, 04:26 PM
COATS LONNELChief Executive OfficerNov 16, 2023 Buy$1.0590,00094,797914,359Nov 17, 2023, 04:55 PM
Amouyal PhilippeDirectorNov 13, 2023 Buy$1.01200,000201,520240,332Nov 14, 2023, 04:12 PM
COATS LONNELChief Executive OfficerNov 10, 2023 Buy$1.0110,00010,100824,359Nov 13, 2023, 05:31 PM
DEBBANE RAYMONDDirectorOct 12, 2023 Buy$1.03148,820153,8051,340,847Oct 12, 2023, 04:01 PM
DEBBANE RAYMONDDirectorOct 11, 2023 Buy$1.08342,874370,7841,192,027Oct 12, 2023, 04:01 PM
DEBBANE RAYMONDDirectorOct 10, 2023 Buy$1.14508,306579,367849,153Oct 12, 2023, 04:01 PM
WADE JEFFREY LPresident and CFOSep 14, 2023 Buy$1.3810,00013,800264,341Sep 14, 2023, 05:05 PM
McDermott WendyVP, Human ResourcesAug 04, 2023 Buy$1.846,00011,04028,478Aug 07, 2023, 04:13 PM
COATS LONNELChief Executive OfficerJun 29, 2023 Buy$2.1610,00021,600814,359Jun 29, 2023, 04:13 PM
McDermott WendyVP, Human ResourcesJun 23, 2023 Buy$2.4310,00024,30022,478Jun 27, 2023, 04:22 PM
COATS LONNELChief Executive OfficerJun 26, 2023 Buy$2.1810,00021,792804,359Jun 26, 2023, 04:04 PM
COATS LONNELChief Executive OfficerJun 23, 2023 Buy$2.4910,00024,950794,359Jun 26, 2023, 04:04 PM
COATS LONNELChief Executive OfficerJun 22, 2023 Buy$2.3140,00092,400784,359Jun 22, 2023, 04:01 PM
WADE JEFFREY LPresident and CFOJun 20, 2023 Buy$2.3312,00028,000254,341Jun 20, 2023, 04:10 PM
Artal International S.C.A.DirectorJun 05, 2023 Buy$2.6027,775,05072,215,12778,634,381Jun 05, 2023, 04:46 PM
Alexander KristenVP, Finance and AccountingFeb 28, 2023 Option Exercise$2.175,33011,56630,350Mar 01, 2023, 04:56 PM
Seth KiernanVP, Chief Commercial OfficerFeb 28, 2023 Option Exercise$2.1711,81325,63453,136Mar 01, 2023, 04:55 PM
McDermott WendyVP, Human ResourcesFeb 28, 2023 Option Exercise$2.176,46514,02912,478Mar 01, 2023, 04:54 PM
MAIN ALAN JEVP, Innov & Chem SciencesFeb 28, 2023 Option Exercise$2.1720,94645,453212,586Mar 01, 2023, 04:53 PM
Kassler-Taub Kenneth B.SVP, Regulatory & QAFeb 28, 2023 Option Exercise$2.1719,11841,486119,625Mar 01, 2023, 04:51 PM
Granowitz Craig BSVP, Chief Medical OfficerFeb 28, 2023 Option Exercise$2.1712,73227,62815,185Mar 01, 2023, 04:50 PM
Crum Brian TSVP, General Counsel & Secr.Feb 28, 2023 Option Exercise$2.1720,53744,565134,798Mar 01, 2023, 04:49 PM
WADE JEFFREY LPresident and CFOFeb 28, 2023 Option Exercise$2.1730,25565,653242,341Mar 01, 2023, 04:48 PM
COATS LONNELChief Executive OfficerFeb 28, 2023 Option Exercise$2.1750,971110,607744,359Mar 01, 2023, 04:46 PM
Invus US Partners LLCDirectorAug 05, 2022 Buy$2.50147,390368,4755,451,204Aug 09, 2022, 04:48 PM
Artal International S.C.A.DirectorAug 05, 2022 Buy$2.502,426,0706,065,17550,859,331Aug 09, 2022, 04:46 PM
Artal International S.C.A.DirectorAug 01, 2022 Buy$2.5016,173,80040,434,50048,433,261Aug 01, 2022, 04:15 PM
Invus US Partners LLCDirectorAug 01, 2022 Buy$2.50982,6002,456,5005,303,814Aug 01, 2022, 04:15 PM
DEBBANE RAYMONDDirectorAug 01, 2022 Buy$2.50982,6002,456,5005,303,814Aug 01, 2022, 04:13 PM
Alexander KristenVP, Finance and AccountingFeb 28, 2022 Option Exercise$2.853,3379,51016,963Feb 28, 2022, 07:18 PM
Seth KiernanVP, Chief Commercial OfficerFeb 28, 2022 Option Exercise$2.858,26123,54421,867Feb 28, 2022, 07:17 PM
MAIN ALAN JEVP, Innov & Chem SciencesFeb 28, 2022 Option Exercise$2.8519,75656,305175,589Feb 28, 2022, 07:16 PM
Kassler-Taub Kenneth B.SVP, Regulatory & QAFeb 28, 2022 Option Exercise$2.8513,24137,73785,857Feb 28, 2022, 07:15 PM
Crum Brian TSVP, General Counsel & Secr.Feb 28, 2022 Option Exercise$2.8515,05942,91899,458Feb 28, 2022, 07:13 PM
WADE JEFFREY LPresident and CFOFeb 28, 2022 Option Exercise$2.8525,77373,453193,680Feb 28, 2022, 07:12 PM
COATS LONNELChief Executive OfficerFeb 28, 2022 Option Exercise$2.8548,053136,951586,003Feb 28, 2022, 07:11 PM
Tessmer James FVP, Finance & AccountingMar 15, 2021 Option Exercise$3.3112,00039,72083,766Mar 16, 2021, 07:45 PM
Tessmer James FVP, Finance & AccountingMar 15, 2021 Sale$6.9222,912158,44071,766Mar 16, 2021, 07:45 PM
WADE JEFFREY LEVP, Corp Adm Affairs and CFOFeb 28, 2021 Option Exercise$7.1926,584191,139157,020Mar 02, 2021, 05:01 PM
TYLE PRAVEENEVP, R&DFeb 28, 2021 Option Exercise$7.1916,560119,066120,791Mar 02, 2021, 12:00 AM
Crum Brian TVP, General Counsel & Secr.Feb 28, 2021 Option Exercise$7.1914,860106,84373,637Mar 02, 2021, 12:00 AM
MAIN ALAN JEVP, Innov & Chem SciencesFeb 28, 2021 Option Exercise$7.1920,413146,769140,695Mar 02, 2021, 12:00 AM
COATS LONNELPresident and CEOFeb 28, 2021 Option Exercise$7.1955,038395,723436,713Mar 02, 2021, 12:00 AM
Tessmer James FVP, Finance & AccountingFeb 28, 2021 Option Exercise$7.1910,76577,40082,678Mar 02, 2021, 12:00 AM
Artal International S.C.A.DirectorDec 16, 2020 Buy$3.2010,937,50035,000,00132,259,461Dec 17, 2020, 02:43 PM
Invus Public Equities, L.P.DirectorDec 16, 2020 Buy$3.2010,937,50035,000,00132,259,461Dec 17, 2020, 02:39 PM
WADE JEFFREY LEVP, Corp Adm Affairs and CFOApr 22, 2020 Option Exercise$1.969,65118,916115,495Apr 24, 2020, 05:24 PM
TYLE PRAVEENEVP, R&DApr 22, 2020 Option Exercise$1.964,8449,49469,344Apr 24, 2020, 05:20 PM
Tessmer James FVP, Finance & AccountingApr 22, 2020 Option Exercise$1.963,9977,83465,127Apr 24, 2020, 05:15 PM
Santini Alexander AEVP and CCOApr 22, 2020 Option Exercise$1.966,81313,35355,584Apr 24, 2020, 05:12 PM
MAIN ALAN JEVP, Commercial Supply OpsApr 22, 2020 Option Exercise$1.966,81313,353104,640Apr 24, 2020, 05:08 PM
Crum Brian TVP, General Counsel & Secr.Apr 22, 2020 Option Exercise$1.966,39812,54049,732Apr 24, 2020, 05:05 PM
Lapuerta PabloEVP and CMOApr 22, 2020 Option Exercise$1.966,81313,35385,719Apr 24, 2020, 05:02 PM
Santini Alexander AEVP and CCOFeb 28, 2020 Option Exercise$2.7712,42034,40342,504Mar 03, 2020, 04:16 PM
Lapuerta PabloEVP and CMOFeb 28, 2020 Option Exercise$2.7713,30536,85572,639Mar 03, 2020, 04:15 PM
MAIN ALAN JEVP, Commercial Supply OpsFeb 28, 2020 Option Exercise$2.7712,75935,34291,560Mar 03, 2020, 04:13 PM
Crum Brian TVP, General Counsel & Secr.Feb 28, 2020 Option Exercise$2.776,94019,22436,237Mar 03, 2020, 04:12 PM
COATS LONNELPresident and CEOFeb 28, 2020 Option Exercise$2.7745,320125,536298,866Mar 03, 2020, 04:11 PM
WADE JEFFREY LEVP, Corp Adm Affairs and CFOFeb 28, 2020 Option Exercise$2.7716,02544,38998,621Mar 03, 2020, 12:00 AM
Tessmer James FVP, Finance & AccountingFeb 28, 2020 Option Exercise$2.773,90210,80955,862Mar 03, 2020, 12:00 AM
COATS LONNELPresident and CEOSep 18, 2019 Buy$3.1050,000155,000227,539Sep 19, 2019, 04:28 PM
Santini Alexander AEVP and CCOSep 18, 2019 Buy$3.364,50015,11518,661Sep 19, 2019, 04:26 PM
COATS LONNELPresident and CEOSep 17, 2019 Buy$3.1350,000156,403177,539Sep 18, 2019, 04:39 PM
DEBBANE RAYMONDDirectorSep 16, 2019 Buy$2.7293,773254,785313,417Sep 17, 2019, 05:36 PM
DEBBANE RAYMONDDirectorSep 13, 2019 Buy$2.469,26922,806219,644Sep 17, 2019, 05:36 PM
DEBBANE RAYMONDDirectorSep 13, 2019 Buy$2.40197,473474,760210,375Sep 17, 2019, 05:33 PM
SOBECKI CHRISTOPHER JDirectorSep 16, 2019 Buy$2.5525,00063,718137,293Sep 17, 2019, 05:27 PM
SOBECKI CHRISTOPHER JDirectorSep 13, 2019 Buy$2.4199,249238,750112,293Sep 17, 2019, 05:23 PM
COATS LONNELPresident and CEOAug 19, 2019 Buy$1.403,0004,194127,539Aug 20, 2019, 05:02 PM
COATS LONNELPresident and CEOAug 16, 2019 Buy$1.3537,00049,835124,539Aug 20, 2019, 05:02 PM
Tessmer James FVP, Finance & AccountingAug 02, 2019 Buy$1.1410,00011,40043,368Aug 02, 2019, 04:15 PM
BARKER SAM LDirectorAug 02, 2019 Buy$1.1724,00028,20052,187Aug 02, 2019, 04:12 PM
WADE JEFFREY LEVP, Corp Adm Affairs and CFOFeb 28, 2019 Option Exercise$5.518,63947,60172,508Mar 01, 2019, 05:20 PM
Tessmer James FVP, Finance & AccountingFeb 28, 2019 Option Exercise$5.512,50113,78133,368Mar 01, 2019, 05:18 PM
Santini Alexander AEVP and CCOFeb 28, 2019 Option Exercise$5.514,54425,03714,161Mar 01, 2019, 05:18 PM
MAIN ALAN JEVP, Commercial Supply OpsFeb 28, 2019 Option Exercise$5.516,88537,93667,067Mar 01, 2019, 05:17 PM
Lapuerta PabloEVP and CMOFeb 28, 2019 Option Exercise$5.516,80937,51847,098Mar 01, 2019, 05:16 PM
COATS LONNELPresident and CEOFeb 28, 2019 Option Exercise$5.5118,641102,71287,539Mar 01, 2019, 05:15 PM
Invus Public Equities, L.P.DirectorJun 28, 2018 Buy$12.4557,724718,9353,516,214Jun 29, 2018, 04:23 PM
Invus Public Equities, L.P.DirectorJun 27, 2018 Buy$12.54125,1141,568,4423,458,490Jun 29, 2018, 04:23 PM
Invus Public Equities, L.P.DirectorJun 25, 2018 Buy$12.95228,2642,955,0833,333,376Jun 26, 2018, 05:32 PM
Invus Public Equities, L.P.DirectorJun 22, 2018 Buy$13.3625,461340,0903,105,112Jun 26, 2018, 05:32 PM
Invus Public Equities, L.P.DirectorJun 21, 2018 Buy$13.2751,600684,6133,079,651Jun 21, 2018, 05:55 PM
Invus Public Equities, L.P.DirectorJun 20, 2018 Buy$13.2812,391164,6133,028,051Jun 21, 2018, 05:55 PM
Invus Public Equities, L.P.DirectorJun 19, 2018 Buy$13.458,982120,8193,015,660Jun 21, 2018, 05:55 PM
Invus Public Equities, L.P.DirectorJun 14, 2018 Buy$12.669,200116,4622,970,094Jun 18, 2018, 06:56 PM
Invus Public Equities, L.P.DirectorJun 18, 2018 Buy$13.0636,584477,9373,006,678Jun 18, 2018, 06:56 PM
Invus Public Equities, L.P.DirectorJun 12, 2018 Buy$12.83107,0231,373,2442,960,894Jun 12, 2018, 06:10 PM
Invus Public Equities, L.P.DirectorJun 11, 2018 Buy$12.7598,6261,257,4522,853,871Jun 12, 2018, 06:10 PM
Invus Public Equities, L.P.DirectorJun 08, 2018 Buy$12.8929,747383,4272,755,245Jun 12, 2018, 06:10 PM
Tessmer James FVP, Finance & AccountingJun 08, 2018 Option Exercise$10.1510,000101,50035,643Jun 12, 2018, 04:37 PM
Tessmer James FVP, Finance & AccountingJun 08, 2018 Sale$12.9110,000129,07625,643Jun 12, 2018, 04:37 PM
Invus Public Equities, L.P.DirectorJun 06, 2018 Buy$12.5895,0791,196,3702,668,059Jun 07, 2018, 07:37 PM
Invus Public Equities, L.P.DirectorJun 05, 2018 Buy$12.45173,1212,156,1872,572,980Jun 07, 2018, 07:37 PM
Invus Public Equities, L.P.DirectorJun 07, 2018 Buy$12.9357,439742,5082,725,498Jun 07, 2018, 07:37 PM
Invus Public Equities, L.P.DirectorJun 04, 2018 Buy$12.24121,8031,490,5762,399,859Jun 04, 2018, 05:31 PM
Invus Public Equities, L.P.DirectorJun 01, 2018 Buy$12.22147,3391,800,0412,278,056Jun 04, 2018, 05:31 PM
Invus Public Equities, L.P.DirectorMay 31, 2018 Buy$11.62147,3391,712,0502,130,717Jun 04, 2018, 05:31 PM
Invus Public Equities, L.P.DirectorMay 29, 2018 Buy$9.84147,3391,450,4201,836,039May 30, 2018, 08:53 PM
Invus Public Equities, L.P.DirectorMay 25, 2018 Buy$9.62138,7001,334,9741,688,700May 30, 2018, 08:53 PM
Invus Public Equities, L.P.DirectorMay 30, 2018 Buy$10.32147,3391,521,0251,983,378May 30, 2018, 08:53 PM
Santini Alexander AEVP and CCOMay 23, 2018 Buy$9.787457,2865,297May 25, 2018, 04:43 PM
WADE JEFFREY LEVP, Corp Adm Affairs and CFOFeb 28, 2018 Option Exercise$8.536,13352,31459,492Mar 02, 2018, 05:12 PM
TYLE PRAVEENEVP, R&DFeb 28, 2018 Option Exercise$8.537286,2102,262Mar 02, 2018, 05:11 PM
Tessmer James FVP, Finance & AccountingFeb 28, 2018 Option Exercise$8.531,80515,39725,643Mar 02, 2018, 05:11 PM
Santini Alexander AEVP and CCOFeb 28, 2018 Option Exercise$8.531,65214,0924,552Mar 02, 2018, 05:09 PM
MAIN ALAN JEVP, Commercial Supply OpsFeb 28, 2018 Option Exercise$8.534,96242,32653,801Mar 02, 2018, 05:08 PM
Lapuerta PabloEVP and CMOFeb 28, 2018 Option Exercise$8.534,82241,13233,975Mar 02, 2018, 05:08 PM
COATS LONNELPresident and CEOFeb 28, 2018 Option Exercise$8.539,49480,98458,079Mar 02, 2018, 05:07 PM
Invus Public Equities, L.P.DirectorNov 15, 2017 Buy$10.21130,7271,334,3961,500,000Nov 17, 2017, 08:09 PM
Invus Public Equities, L.P.DirectorNov 17, 2017 Buy$9.8550,000492,5001,550,000Nov 17, 2017, 08:09 PM
COATS LONNELPresident and CEONov 15, 2017 Buy$9.9110,00099,10042,985Nov 15, 2017, 05:15 PM
Invus Public Equities, L.P.DirectorNov 14, 2017 Buy$9.47215,1332,037,8471,369,273Nov 14, 2017, 07:32 PM
Invus Public Equities, L.P.DirectorNov 13, 2017 Buy$9.75215,1332,097,9341,154,140Nov 14, 2017, 07:32 PM
Invus Public Equities, L.P.DirectorNov 10, 2017 Buy$9.74145,6801,418,384939,007Nov 14, 2017, 07:32 PM
WADE JEFFREY LEVP, Corp Adm Affairs and CFONov 14, 2017 Buy$9.482,00018,96250,597Nov 14, 2017, 06:55 PM
COATS LONNELPresident and CEOSep 15, 2017 Buy$12.5430,000376,33732,985Sep 18, 2017, 06:40 AM
BARKER SAM LDirectorSep 15, 2017 Buy$12.501,00012,50025,623Sep 18, 2017, 06:36 AM
Tessmer James FVP, Finance & AccountingFeb 28, 2017 Option Exercise$16.452,79045,89620,095Mar 01, 2017, 06:53 PM
WADE JEFFREY LEVP, Corp Adm Affairs and CFOFeb 28, 2017 Option Exercise$16.456,455106,18548,597Mar 01, 2017, 06:52 PM
Santini Alexander AEVP and CCOFeb 28, 2017 Option Exercise$16.451,09317,9801,259Mar 01, 2017, 06:51 PM
MAIN ALAN JEVP, CMC and Supply OperationsFeb 28, 2017 Option Exercise$16.455,36188,18844,230Mar 01, 2017, 06:50 PM
Lapuerta PabloEVP and CMOFeb 28, 2017 Option Exercise$16.455,25286,39524,613Mar 01, 2017, 06:49 PM
COATS LONNELPresident and CEOFeb 28, 2017 Option Exercise$16.455,25886,49420,767Mar 01, 2017, 06:48 PM
Tessmer James FVP, Finance & AccountingJun 06, 2016 Option Exercise$6.231,5009,34517,446Jun 08, 2016, 08:22 AM
Tessmer James FVP, Finance & AccountingJun 06, 2016 Sale$15.001,50022,50015,946Jun 08, 2016, 08:22 AM
Tessmer James FVP, Finance & AccountingMay 23, 2016 Option Exercise$6.236,00037,38021,946May 23, 2016, 05:56 PM
Tessmer James FVP, Finance & AccountingMay 23, 2016 Sale$13.006,00078,00015,946May 23, 2016, 05:56 PM
WADE JEFFREY LEVP, Corp Adm Affairs and CFOFeb 29, 2016 Option Exercise$9.073,81534,60239,393Mar 02, 2016, 08:46 AM
MAIN ALAN JEVP, CMC and Supply OperationsFeb 29, 2016 Option Exercise$9.074,75443,11935,200Mar 02, 2016, 08:46 AM
Lapuerta PabloEVP and CMOFeb 29, 2016 Option Exercise$9.074,35739,51815,766Mar 02, 2016, 08:45 AM
COATS LONNELPresident and CEOFeb 29, 2016 Option Exercise$9.074,03636,6076,799Mar 02, 2016, 08:44 AM
Tessmer James FVP, Finance & AccountingFeb 29, 2016 Option Exercise$9.071,62614,74815,946Mar 02, 2016, 08:43 AM
Lapuerta PabloEVP and CMOMar 02, 2015 Option Exercise$0.9418,26617,17058,767Mar 03, 2015, 04:11 PM
MAIN ALAN JEVP, CMC and Supply OperationsMar 02, 2015 Option Exercise$0.9425,31823,799190,032Mar 03, 2015, 04:10 PM
NORTHCOTT JOHNVP, Marketing, Comm StrategyMar 02, 2015 Option Exercise$0.943,0152,8348,235Mar 03, 2015, 04:08 PM
Tessmer James FVP, Finance & AccountingMar 02, 2015 Option Exercise$0.949,0418,49982,225Mar 03, 2015, 04:06 PM
WADE JEFFREY LEVP, Corp Adm Affairs and CFOMar 02, 2015 Option Exercise$0.9420,71819,475204,821Mar 03, 2015, 04:04 PM
Invus C.V.DirectorDec 12, 2014 Buy$0.88150,000132,03030,248,505Dec 12, 2014, 07:02 PM
Invus C.V.DirectorDec 10, 2014 Buy$0.90315,896285,34930,098,505Dec 10, 2014, 09:14 PM
Artal International S.C.A.DirectorNov 26, 2014 Buy$1.00149,253,731149,999,999149,253,731Nov 26, 2014, 07:19 PM
SANDS ARTHUR TPresident & CEOFeb 28, 2014 Option Exercise$1.9229,79157,1991,021,329Mar 03, 2014, 06:20 PM
Lapuerta PabloEVP, Clin Dev and CMOFeb 28, 2014 Option Exercise$1.9211,99223,02526,783Mar 03, 2014, 06:19 PM
MAIN ALAN JEVP, Pharmaceutical ResearchFeb 28, 2014 Option Exercise$1.9218,66835,843146,350Mar 03, 2014, 06:18 PM
Tessmer James FVP, Finance & AccountingFeb 28, 2014 Option Exercise$1.926,61212,69561,641Mar 03, 2014, 06:17 PM
ZAMBROWICZ BRIAN PEVP, Chief Scientific OfficerFeb 28, 2014 Option Exercise$1.9218,18634,917278,703Mar 03, 2014, 06:16 PM
WADE JEFFREY LEVP, Corp Dev and CFOFeb 28, 2014 Option Exercise$1.9216,29731,290149,789Mar 03, 2014, 06:15 PM
MAIN ALAN JEVP, Pharmaceutical ResearchFeb 28, 2013 Option Exercise$1.9812,57224,893114,768Mar 01, 2013, 05:30 PM
Lapuerta PabloEVP, Clin Dev and CMOFeb 28, 2013 Option Exercise$1.984,7259,3568,275Mar 01, 2013, 05:29 PM
SANDS ARTHUR TPresident & CEOFeb 28, 2013 Option Exercise$1.9820,03439,667942,870Mar 01, 2013, 05:27 PM
Tessmer James FVP, Finance & AccountingFeb 28, 2013 Option Exercise$1.983,8077,53848,003Mar 01, 2013, 05:26 PM
WADE JEFFREY LEVP, Corp Dev and CFOFeb 28, 2013 Option Exercise$1.9810,46120,713110,836Mar 01, 2013, 05:24 PM
ZAMBROWICZ BRIAN PEVP, Chief Scientific OfficerFeb 28, 2013 Option Exercise$1.9811,69223,150234,139Mar 01, 2013, 05:22 PM
WADE JEFFREY LEVP, Corp Dev and CFOJan 31, 2013 Option Exercise$2.1110,31721,76983,047Feb 04, 2013, 05:04 PM
SANDS ARTHUR TPresident & CEOJan 31, 2013 Option Exercise$2.1121,43445,226889,654Feb 04, 2013, 05:02 PM
ZAMBROWICZ BRIAN PEVP, Chief Scientific OfficerJan 31, 2013 Option Exercise$2.1113,49928,483203,081Feb 04, 2013, 05:00 PM
MAIN ALAN JEVP, Pharmaceutical ResearchJan 31, 2013 Option Exercise$2.1112,53726,45393,590Feb 04, 2013, 04:58 PM
Tessmer James FVP, Finance & AccountingJan 31, 2013 Option Exercise$2.114,3109,09437,560Feb 04, 2013, 04:56 PM
Invus, CVDirectorOct 23, 2012 Buy$2.253,000,0006,750,000283,154,744Oct 25, 2012, 05:21 PM
Artal International S.C.A.DirectorOct 23, 2012 Buy$2.253,000,0006,750,000283,154,744Oct 25, 2012, 05:21 PM
Tessmer James FVP, Finance & AccountingFeb 28, 2012 Option Exercise$1.782,2994,09228,670Mar 01, 2012, 04:07 PM
MAIN ALAN JEVP, Pharmaceutical ResearchFeb 28, 2012 Option Exercise$1.785,90710,51458,277Mar 01, 2012, 04:07 PM
WADE JEFFREY LEVP, Corp Dev and CFOFeb 28, 2012 Option Exercise$1.784,9598,82761,764Mar 01, 2012, 04:06 PM
ZAMBROWICZ BRIAN PEVP, Chief Scientific OfficerFeb 28, 2012 Option Exercise$1.785,62110,005174,480Mar 01, 2012, 04:05 PM
SANDS ARTHUR TPresident & CEOFeb 28, 2012 Option Exercise$1.789,58817,067837,388Mar 01, 2012, 04:04 PM
Ulys, LLCDirectorDec 22, 2011 Option Exercise$1.13115,004,247129,954,799250,372,135Dec 27, 2011, 05:26 PM
MAIN ALAN JEVP, Pharmaceutical ResearchDec 22, 2011 Option Exercise$1.1319,21121,70864,184Dec 27, 2011, 04:12 PM
BARKER SAM LDirectorDec 22, 2011 Option Exercise$1.1334,00038,420100,000Dec 27, 2011, 04:12 PM
SANDS ARTHUR TPresident & CEODec 22, 2011 Option Exercise$1.1325,00028,250810,726Dec 27, 2011, 04:10 PM
MAIN ALAN JEVP, Pharmaceutical ResearchFeb 23, 2011 Option Exercise$1.815,92610,72644,973Feb 25, 2011, 04:41 PM
Tessmer James FVP, Finance & AccountingFeb 23, 2011 Option Exercise$1.812,1163,83023,469Feb 25, 2011, 04:40 PM
SANDS ARTHUR TPresident & CEOFeb 23, 2011 Option Exercise$1.8110,46418,940785,726Feb 25, 2011, 04:38 PM
WADE JEFFREY LEVP, Corp Dev and CFOFeb 23, 2011 Option Exercise$1.815,92610,72647,973Feb 25, 2011, 04:37 PM
ZAMBROWICZ BRIAN PEVP, Chief Scientific OfficerFeb 23, 2011 Option Exercise$1.817,88114,265158,851Feb 25, 2011, 04:35 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Artal International S.C.A.Director03/13/2024124,875,037
Alexander KristenVP, Finance and Accounting02/28/202430,898
WADE JEFFREY LPresident and CFO02/28/202498,750
McDermott WendyVP, Human Resources02/28/202458,753
MAIN ALAN JEVP, Innov & Chem Sciences02/28/202463,949
Kassler-Taub Kenneth B.SVP, Regulatory & QA02/28/202463,805
Granowitz Craig BSVP, Chief Medical Officer02/28/202481,914
Crum Brian TSVP, General Counsel & Secr.02/28/202467,082
COATS LONNELChief Executive Officer02/28/2024160,792
COATS LONNELChief Executive Officer11/16/202394,797
Amouyal PhilippeDirector11/13/2023201,520
COATS LONNELChief Executive Officer11/10/202310,100
DEBBANE RAYMONDDirector10/12/2023153,805
DEBBANE RAYMONDDirector10/11/2023370,784
DEBBANE RAYMONDDirector10/10/2023579,367
WADE JEFFREY LPresident and CFO09/14/202313,800
McDermott WendyVP, Human Resources08/04/202311,040
COATS LONNELChief Executive Officer06/29/202321,600
McDermott WendyVP, Human Resources06/23/202324,300
COATS LONNELChief Executive Officer06/26/202321,792
COATS LONNELChief Executive Officer06/23/202324,950
COATS LONNELChief Executive Officer06/22/202392,400
WADE JEFFREY LPresident and CFO06/20/202328,000
Artal International S.C.A.Director06/05/202372,215,127
Alexander KristenVP, Finance and Accounting02/28/202311,566
Seth KiernanVP, Chief Commercial Officer02/28/202325,634
McDermott WendyVP, Human Resources02/28/202314,029
MAIN ALAN JEVP, Innov & Chem Sciences02/28/202345,453
Kassler-Taub Kenneth B.SVP, Regulatory & QA02/28/202341,486
Granowitz Craig BSVP, Chief Medical Officer02/28/202327,628
Crum Brian TSVP, General Counsel & Secr.02/28/202344,565
WADE JEFFREY LPresident and CFO02/28/202365,653
COATS LONNELChief Executive Officer02/28/2023110,607
Invus US Partners LLCDirector08/05/2022368,475
Artal International S.C.A.Director08/05/20226,065,175
Artal International S.C.A.Director08/01/202240,434,500
Invus US Partners LLCDirector08/01/20222,456,500
DEBBANE RAYMONDDirector08/01/20222,456,500
Alexander KristenVP, Finance and Accounting02/28/20229,510
Seth KiernanVP, Chief Commercial Officer02/28/202223,544
MAIN ALAN JEVP, Innov & Chem Sciences02/28/202256,305
Kassler-Taub Kenneth B.SVP, Regulatory & QA02/28/202237,737
Crum Brian TSVP, General Counsel & Secr.02/28/202242,918
WADE JEFFREY LPresident and CFO02/28/202273,453
COATS LONNELChief Executive Officer02/28/2022136,951
Tessmer James FVP, Finance & Accounting03/15/202139,720
Tessmer James FVP, Finance & Accounting03/15/2021158,440
WADE JEFFREY LEVP, Corp Adm Affairs and CFO02/28/2021191,139
TYLE PRAVEENEVP, R&D02/28/2021119,066
Crum Brian TVP, General Counsel & Secr.02/28/2021106,843
MAIN ALAN JEVP, Innov & Chem Sciences02/28/2021146,769
COATS LONNELPresident and CEO02/28/2021395,723
Tessmer James FVP, Finance & Accounting02/28/202177,400
Artal International S.C.A.Director12/16/202035,000,001
Invus Public Equities, L.P.Director12/16/202035,000,001
WADE JEFFREY LEVP, Corp Adm Affairs and CFO04/22/202018,916
TYLE PRAVEENEVP, R&D04/22/20209,494
Tessmer James FVP, Finance & Accounting04/22/20207,834
Santini Alexander AEVP and CCO04/22/202013,353
MAIN ALAN JEVP, Commercial Supply Ops04/22/202013,353
Crum Brian TVP, General Counsel & Secr.04/22/202012,540
Lapuerta PabloEVP and CMO04/22/202013,353
Santini Alexander AEVP and CCO02/28/202034,403
Lapuerta PabloEVP and CMO02/28/202036,855
MAIN ALAN JEVP, Commercial Supply Ops02/28/202035,342
Crum Brian TVP, General Counsel & Secr.02/28/202019,224
COATS LONNELPresident and CEO02/28/2020125,536
WADE JEFFREY LEVP, Corp Adm Affairs and CFO02/28/202044,389
Tessmer James FVP, Finance & Accounting02/28/202010,809
COATS LONNELPresident and CEO09/18/2019155,000
Santini Alexander AEVP and CCO09/18/201915,115
COATS LONNELPresident and CEO09/17/2019156,403
DEBBANE RAYMONDDirector09/16/2019254,785
DEBBANE RAYMONDDirector09/13/201922,806
DEBBANE RAYMONDDirector09/13/2019474,760
SOBECKI CHRISTOPHER JDirector09/16/201963,718
SOBECKI CHRISTOPHER JDirector09/13/2019238,750
COATS LONNELPresident and CEO08/19/20194,194
COATS LONNELPresident and CEO08/16/201949,835
Tessmer James FVP, Finance & Accounting08/02/201911,400
BARKER SAM LDirector08/02/201928,200
WADE JEFFREY LEVP, Corp Adm Affairs and CFO02/28/201947,601
Tessmer James FVP, Finance & Accounting02/28/201913,781
Santini Alexander AEVP and CCO02/28/201925,037
MAIN ALAN JEVP, Commercial Supply Ops02/28/201937,936
Lapuerta PabloEVP and CMO02/28/201937,518
COATS LONNELPresident and CEO02/28/2019102,712
Invus Public Equities, L.P.Director06/28/2018718,935
Invus Public Equities, L.P.Director06/27/20181,568,442
Invus Public Equities, L.P.Director06/25/20182,955,083
Invus Public Equities, L.P.Director06/22/2018340,090
Invus Public Equities, L.P.Director06/21/2018684,613
Invus Public Equities, L.P.Director06/20/2018164,613
Invus Public Equities, L.P.Director06/19/2018120,819
Invus Public Equities, L.P.Director06/14/2018116,462
Invus Public Equities, L.P.Director06/18/2018477,937
Invus Public Equities, L.P.Director06/12/20181,373,244
Invus Public Equities, L.P.Director06/11/20181,257,452
Invus Public Equities, L.P.Director06/08/2018383,427
Tessmer James FVP, Finance & Accounting06/08/2018101,500
Tessmer James FVP, Finance & Accounting06/08/2018129,076
Invus Public Equities, L.P.Director06/06/20181,196,370
Invus Public Equities, L.P.Director06/05/20182,156,187
Invus Public Equities, L.P.Director06/07/2018742,508
Invus Public Equities, L.P.Director06/04/20181,490,576
Invus Public Equities, L.P.Director06/01/20181,800,041
Invus Public Equities, L.P.Director05/31/20181,712,050
Invus Public Equities, L.P.Director05/29/20181,450,420
Invus Public Equities, L.P.Director05/25/20181,334,974
Invus Public Equities, L.P.Director05/30/20181,521,025
Santini Alexander AEVP and CCO05/23/20187,286
WADE JEFFREY LEVP, Corp Adm Affairs and CFO02/28/201852,314
TYLE PRAVEENEVP, R&D02/28/20186,210
Tessmer James FVP, Finance & Accounting02/28/201815,397
Santini Alexander AEVP and CCO02/28/201814,092
MAIN ALAN JEVP, Commercial Supply Ops02/28/201842,326
Lapuerta PabloEVP and CMO02/28/201841,132
COATS LONNELPresident and CEO02/28/201880,984
Invus Public Equities, L.P.Director11/15/20171,334,396
Invus Public Equities, L.P.Director11/17/2017492,500
COATS LONNELPresident and CEO11/15/201799,100
Invus Public Equities, L.P.Director11/14/20172,037,847
Invus Public Equities, L.P.Director11/13/20172,097,934
Invus Public Equities, L.P.Director11/10/20171,418,384
WADE JEFFREY LEVP, Corp Adm Affairs and CFO11/14/201718,962
COATS LONNELPresident and CEO09/15/2017376,337
BARKER SAM LDirector09/15/201712,500
Tessmer James FVP, Finance & Accounting02/28/201745,896
WADE JEFFREY LEVP, Corp Adm Affairs and CFO02/28/2017106,185
Santini Alexander AEVP and CCO02/28/201717,980
MAIN ALAN JEVP, CMC and Supply Operations02/28/201788,188
Lapuerta PabloEVP and CMO02/28/201786,395
COATS LONNELPresident and CEO02/28/201786,494
Tessmer James FVP, Finance & Accounting06/06/20169,345
Tessmer James FVP, Finance & Accounting06/06/201622,500
Tessmer James FVP, Finance & Accounting05/23/201637,380
Tessmer James FVP, Finance & Accounting05/23/201678,000
WADE JEFFREY LEVP, Corp Adm Affairs and CFO02/29/201634,602
MAIN ALAN JEVP, CMC and Supply Operations02/29/201643,119
Lapuerta PabloEVP and CMO02/29/201639,518
COATS LONNELPresident and CEO02/29/201636,607
Tessmer James FVP, Finance & Accounting02/29/201614,748
Lapuerta PabloEVP and CMO03/02/201517,170
MAIN ALAN JEVP, CMC and Supply Operations03/02/201523,799
NORTHCOTT JOHNVP, Marketing, Comm Strategy03/02/20152,834
Tessmer James FVP, Finance & Accounting03/02/20158,499
WADE JEFFREY LEVP, Corp Adm Affairs and CFO03/02/201519,475
Invus C.V.Director12/12/2014132,030
Invus C.V.Director12/10/2014285,349
Artal International S.C.A.Director11/26/2014149,999,999
SANDS ARTHUR TPresident & CEO02/28/201457,199
Lapuerta PabloEVP, Clin Dev and CMO02/28/201423,025
MAIN ALAN JEVP, Pharmaceutical Research02/28/201435,843
Tessmer James FVP, Finance & Accounting02/28/201412,695
ZAMBROWICZ BRIAN PEVP, Chief Scientific Officer02/28/201434,917
WADE JEFFREY LEVP, Corp Dev and CFO02/28/201431,290
MAIN ALAN JEVP, Pharmaceutical Research02/28/201324,893
Lapuerta PabloEVP, Clin Dev and CMO02/28/20139,356
SANDS ARTHUR TPresident & CEO02/28/201339,667
Tessmer James FVP, Finance & Accounting02/28/20137,538
WADE JEFFREY LEVP, Corp Dev and CFO02/28/201320,713
ZAMBROWICZ BRIAN PEVP, Chief Scientific Officer02/28/201323,150
WADE JEFFREY LEVP, Corp Dev and CFO01/31/201321,769
SANDS ARTHUR TPresident & CEO01/31/201345,226
ZAMBROWICZ BRIAN PEVP, Chief Scientific Officer01/31/201328,483
MAIN ALAN JEVP, Pharmaceutical Research01/31/201326,453
Tessmer James FVP, Finance & Accounting01/31/20139,094
Invus, CVDirector10/23/20126,750,000
Artal International S.C.A.Director10/23/20126,750,000
Tessmer James FVP, Finance & Accounting02/28/20124,092
MAIN ALAN JEVP, Pharmaceutical Research02/28/201210,514
WADE JEFFREY LEVP, Corp Dev and CFO02/28/20128,827
ZAMBROWICZ BRIAN PEVP, Chief Scientific Officer02/28/201210,005
SANDS ARTHUR TPresident & CEO02/28/201217,067
Ulys, LLCDirector12/22/2011129,954,799
MAIN ALAN JEVP, Pharmaceutical Research12/22/201121,708
BARKER SAM LDirector12/22/201138,420
SANDS ARTHUR TPresident & CEO12/22/201128,250
MAIN ALAN JEVP, Pharmaceutical Research02/23/201110,726
Tessmer James FVP, Finance & Accounting02/23/20113,830
SANDS ARTHUR TPresident & CEO02/23/201118,940
WADE JEFFREY LEVP, Corp Dev and CFO02/23/201110,726
ZAMBROWICZ BRIAN PEVP, Chief Scientific Officer02/23/201114,265
Load More Insider Transactions
FUNDS WITH A POSITION IN LEXICON PHARMACEUTICALS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.7,005,1530.00027%5.26%Other
GEODE CAPITAL MANAGEMENT, LLC2,348,9160.00038%10.48%Other
D. E. SHAW & CO., INC.359,2100.00048%-54.19%Other
FISHER ASSET MANAGEMENT, LLC523,3940.00066%ExitedOther
RENAISSANCE TECHNOLOGIES LLC412,1750.00098%51.39%Other
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)103,1440.00291%NewOther
TUDOR INVESTMENT CORP ET AL47,1010.00058%No changeEvent Driven, Other
AQR CAPITAL MANAGEMENT LLC29,5580.00007%ExitedOther
CHANGE IN SHARES OUTSTANDING FOR LEXICON PHARMACEUTICALS INC
STOCK BUYBACKS FOR LEXICON PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.11%
1Q
12/31/2023
06/30/2023
19.73%
2Q
12/31/2023
03/31/2023
29.72%
3Q
12/31/2023
12/31/2022
29.74%
4Q
12/31/2023
09/30/2022
40.18%
5Q
12/31/2023
06/30/2022
63.88%
6Q
12/31/2023
03/31/2022
64.39%
7Q
12/31/2023
12/31/2021
64.63%
8Q
12/31/2023
09/30/2021
68.14%
9Q
12/31/2023
06/30/2021
69.74%
10Q
12/31/2023
03/31/2021
71.00%
11Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.11%
1Q
06/30/2023
19.73%
2Q
03/31/2023
29.72%
3Q
12/31/2022
29.74%
4Q
09/30/2022
40.18%
5Q
06/30/2022
63.88%
6Q
03/31/2022
64.39%
7Q
12/31/2021
64.63%
8Q
09/30/2021
68.14%
9Q
06/30/2021
69.74%
10Q
03/31/2021
71.00%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR LEXICON PHARMACEUTICALS INC
LOADING...